Literature DB >> 24865357

Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes.

Gordon J G Asmundson1, Steven Taylor, Jasper A J Smits.   

Abstract

The recently published DSM-5 contains a number of changes pertinent to panic disorder and agoraphobia. These changes include separation of panic disorder and agoraphobia into separate diagnoses, the addition of criteria and guidelines for distinguishing agoraphobia from specific phobia, the addition of a 6-month duration requirement for agoraphobia, the addition of panic attacks as a specifier to any DSM-5 diagnosis, changes to descriptors of panic attack types, as well as various changes to the descriptive text. It is crucial that clinicians and researchers working with individuals presenting with panic attacks and panic-like symptoms understand these changes. The purpose of the current paper is to provide a summary of the main changes, to critique the changes in the context of available empirical evidence, and to highlight clinical implications and potential impact on mental health service utilization. Several of the changes have the potential to improve access to evidence-based treatment; yet, although certain changes appear justified in that they were based on converging evidence from different empirical sources, other changes appear questionable, at least based on the information presented in the DSM-5 text and related publications. Ongoing research of DSM-5 panic disorder and agoraphobia as well as application of the new diagnostic criteria in clinical contexts is needed to further inform the strengths and limitations of DSM-5 conceptualizations of panic disorder and agoraphobia.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  DSM-5; agoraphobia; classification; diagnosis; panic disorder

Mesh:

Year:  2014        PMID: 24865357     DOI: 10.1002/da.22277

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  9 in total

1.  Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.

Authors:  Jasper A J Smits; Michael J Zvolensky; Michael W Otto; Megan E Piper; Scarlett O Baird; Brooke Y Kauffman; Eunjung Lee-Furman; Noura Alavi; Christina D Dutcher; Santiago Papini; Benjamin Rosenfield; David Rosenfield
Journal:  Drug Alcohol Depend       Date:  2020-01-22       Impact factor: 4.492

Review 2.  Defensive and Emotional Behavior Modulation by Serotonin in the Periaqueductal Gray.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Kenji Valencia-Flores; Hugo Sánchez-Castillo
Journal:  Cell Mol Neurobiol       Date:  2022-07-28       Impact factor: 4.231

3.  Evaluation of MINOCA syndrome and HEART score in patients presenting to the emergency department with panic attack and chest pain complaints.

Authors:  Bahadır Taslidere; Ahmet Atsiz
Journal:  Ir J Med Sci       Date:  2022-04-28       Impact factor: 2.089

4.  Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study.

Authors:  Jung-Yoon Heo; Hawoo Yi; Maurizio Fava; David Mischoulon; Kiwon Kim; Sechang Yoon; Hong Jin Jeon; Jeong Eon Lee
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

5.  Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018.

Authors:  Morena M Zugliani; Mariana C Cabo; Antonio E Nardi; Giampaolo Perna; Rafael C Freire
Journal:  Psychiatry Investig       Date:  2019-01-25       Impact factor: 2.505

6.  A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys.

Authors:  Annelieke M Roest; Ymkje Anna de Vries; Carmen C W Lim; Hans-Ulrich Wittchen; Dan J Stein; Tomasz Adamowski; Ali Al-Hamzawi; Evelyn J Bromet; Maria Carmen Viana; Giovanni de Girolamo; Koen Demyttenaere; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; José Miguel Caldas-de-Almeida; Norito Kawakami; Jean Pierre Lépine; Daphna Levinson; Maria E Medina-Mora; Fernando Navarro-Mateu; Siobhan O'Neill; Marina Piazza; José A Posada-Villa; Tim Slade; Yolanda Torres; Ronald C Kessler; Kate M Scott; Peter de Jonge
Journal:  Depress Anxiety       Date:  2019-02-06       Impact factor: 6.505

7.  In vivo investigation on bio-markers of perimenopausal panic disorder and catgut embedding acupoints mechanism.

Authors:  Guizhen Chen; Xue Wang; Shuo Zhang; Xiaokang Xu; Junquan Liang; Yunxiang Xu
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

8.  Association between Uncinate Fasciculus Integrity and Agoraphobia Symptoms in Female Patients with Panic Disorder.

Authors:  Sung Eun Kim; Minji Bang; Eunsoo Won; Sang-Hyuk Lee
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

9.  Clinical implications of agoraphobia in patients with panic disorder.

Authors:  Jin Shin; Doo-Heum Park; Seung-Ho Ryu; Jee Hyun Ha; Seol Min Kim; Hong Jun Jeon
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.